Applied Cell Technology Overview

  • Founded
  • 2013

Founded
  • Status
  • Private

  • Employees
  • 6

Employees
  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $806K

  • Investors
  • 3

Applied Cell Technology General Information

Description

Developer and distributor of patented platform technology designed to enhance cell competence. The company's technology forms genetic materials to improve the effectiveness of cryopreservation by preserving the viability and function of the spermatozoa, enabling clients to ensure significantly improved survival of stem cells, gametes and embryos after interventions.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Other Devices and Supplies
Biotechnology
Primary Office
  • 1 Búza street
  • Gyongyos, 3200
  • Hungary
+36 (06 0) 000 0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Applied Cell Technology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Grant 28-Feb-2018 $806K Completed Generating Revenue
2. Early Stage VC Completed Generating Revenue
1. Early Stage VC 01-Jan-2014 Completed Generating Revenue
To view Applied Cell Technology’s complete valuation and funding history, request access »

Applied Cell Technology Patents

Applied Cell Technology Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20140093864-A1 Increasing the viability and stress tolerance of viable biological material Abandoned 01-Oct-2012 00000000
US-20140329222-A1 Increasing the viability and stress tolerance of viable biological material Abandoned 22-Nov-2005 000000000
ES-2500142-T3 Increased viability and stress tolerance of viable biological material Active 22-Nov-2005 00000000
US-8278031-B2 Increasing the viability of mammalian oocytes Expired - Fee Related 22-Nov-2005 00000000 0
US-20090017440-A1 Increasing the viability and stress tolerance of viable biological material Granted 22-Nov-2005 A01N1/02 0
To view Applied Cell Technology’s complete patent history, request access »

Applied Cell Technology Executive Team (4)

Name Title Board Seat Contact Info
Ákos Tóth Chief Marketing Officer & Chief Technical Officer
Gábor Juhász Co-Founder & General Manager
Judit Cserepes Ph.D Chief Scientific Officer
Csaba Pribenszky Co-Founder
To view Applied Cell Technology’s complete executive team members history, request access »

Applied Cell Technology Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Applied Cell Technology Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
National Research, Development and Innovation Office Government 000 0000 000000 0
Széchenyi Equity Fund Manager Venture Capital Minority 000 0000 000000 0
PortfoLion Corporate Venture Capital Minority 000 0000 000000 0
To view Applied Cell Technology’s complete investors history, request access »